|
IL73534A
(en)
*
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US4938949A
(en)
*
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5238944A
(en)
*
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
US5736553A
(en)
*
|
1988-12-15 |
1998-04-07 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
|
|
US4929624A
(en)
*
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
US5037986A
(en)
*
|
1989-03-23 |
1991-08-06 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
|
|
NZ232740A
(en)
*
|
1989-04-20 |
1992-06-25 |
Riker Laboratories Inc |
Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
|
|
DK0553202T3
(da)
*
|
1990-10-05 |
1995-07-03 |
Minnesota Mining & Mfg |
Fremgangsmåde til fremstilling af imidazo(4,5-c)quinolin-4-aminer
|
|
US5175296A
(en)
*
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US5395937A
(en)
*
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
US5648516A
(en)
*
|
1994-07-20 |
1997-07-15 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5352784A
(en)
*
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5525606A
(en)
*
|
1994-08-01 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
|
|
DE19505168A1
(de)
*
|
1995-02-16 |
1996-08-22 |
Boehringer Mannheim Gmbh |
Spezifische Lipidkonjugate von Nucleosid-Diphosphonaten und deren Verwendung als Arzneimittel
|
|
US5624677A
(en)
*
|
1995-06-13 |
1997-04-29 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
|
US5741908A
(en)
*
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
|
US5693811A
(en)
*
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
|
DE19637209B4
(de)
*
|
1996-09-12 |
2006-12-14 |
Siemens Ag |
Verfahren zum Steuern des Antriebsstrangs eines Kraftfahrzeugs und integrierte Antriebsstrangsteuerung
|
|
IL129319A0
(en)
*
|
1996-10-25 |
2000-02-17 |
Minnesota Mining & Mfg |
Immune response modifier compounds for treatment of TH2 mediated and related diseases
|
|
CN1130363C
(zh)
*
|
1997-11-12 |
2003-12-10 |
三菱化学株式会社 |
嘌呤衍生物以及含有其作为有效成分的药物
|
|
DE69817393T2
(de)
*
|
1997-11-28 |
2004-06-17 |
Sumitomo Pharmaceuticals Co., Ltd. |
Neue heterozyklische verbindungen
|
|
US7001609B1
(en)
*
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
US6486168B1
(en)
*
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
HU229441B1
(en)
*
|
1999-01-08 |
2013-12-30 |
3M Innovative Properties Co |
Formulations and methods for treating mucosal associated conditions with an immune response modifier
|
|
US20020058674A1
(en)
*
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
|
CZ27399A3
(cs)
*
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
IL150594A0
(en)
*
|
2000-01-07 |
2003-02-12 |
Ustav Ex Botan Adademie Ved Ce |
Purine derivatives, process for their preparation and use
|
|
US6533645B2
(en)
*
|
2000-01-18 |
2003-03-18 |
Applied Materials, Inc. |
Substrate polishing article
|
|
US6733764B2
(en)
*
|
2000-06-14 |
2004-05-11 |
Alain Martin |
Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer
|
|
AU1227302A
(en)
*
|
2000-09-15 |
2002-03-26 |
Virco Nv |
System and method for optimizing drug therapy for the treatment of diseases
|
|
WO2002030399A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Johns Hopkins University |
Polymer controlled delivery of a therapeutic agent
|
|
US20020127224A1
(en)
*
|
2001-03-02 |
2002-09-12 |
James Chen |
Use of photoluminescent nanoparticles for photodynamic therapy
|
|
ES2278016T3
(es)
*
|
2001-04-09 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
|
|
US7157465B2
(en)
*
|
2001-04-17 |
2007-01-02 |
Dainippon Simitomo Pharma Co., Ltd. |
Adenine derivatives
|
|
DK1401837T3
(da)
*
|
2001-06-29 |
2005-11-07 |
Cv Therapeutics Inc |
Purinderivater som A2B-adenosinreceptorantagonister
|
|
WO2003037860A2
(en)
*
|
2001-10-30 |
2003-05-08 |
Conforma Therapeutics Corporation |
Purine analogs having hsp90-inhibiting activity
|
|
MXPA05003193A
(es)
*
|
2002-09-27 |
2005-06-08 |
Sumitomo Pharma |
Compuesto de adenina novedoso y uso del mismo.
|
|
US20040202663A1
(en)
*
|
2003-01-28 |
2004-10-14 |
Shanghai Sunway Biotech Co., Ltd. |
Therapy for primary and metastatic cancers
|
|
US20040265351A1
(en)
*
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
US20050004144A1
(en)
*
|
2003-04-14 |
2005-01-06 |
Regents Of The University Of California |
Combined use of IMPDH inhibitors with toll-like receptor agonists
|
|
US20050059613A1
(en)
*
|
2003-07-08 |
2005-03-17 |
Bahram Memarzadeh |
Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
|
|
US20070161582A1
(en)
*
|
2003-08-08 |
2007-07-12 |
Dusan Mijikovic |
Pharmaceutical compositions and methods for metabolic modulation
|
|
JP2007504232A
(ja)
*
|
2003-09-05 |
2007-03-01 |
アナディス ファーマシューティカルズ インク |
Ｃ型肝炎ウイルス感染治療用のｔｌｒ７リガンド及びそのプロドラッグの投与
|
|
MXPA06002997A
(es)
*
|
2003-09-18 |
2007-02-08 |
Conforma Therapeutics Corp |
Novedosos compuestos heterociclicos como inhibidores- hsp90.
|
|
FR2863890B1
(fr)
*
|
2003-12-19 |
2006-03-24 |
Aventis Pasteur |
Composition immunostimulante
|
|
US20050266067A1
(en)
*
|
2004-03-02 |
2005-12-01 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
US8012964B2
(en)
*
|
2004-03-26 |
2011-09-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
9-substituted 8-oxoadenine compound
|
|
CA2587676A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Institut Gustave Roussy |
Improved treatment of cancer by double-stranded rna
|
|
WO2006065234A1
(en)
*
|
2004-12-10 |
2006-06-22 |
University Of Pittsburgh |
Use of lipid and hydrogel vehicles for treatment and drug delivery
|
|
US20070292418A1
(en)
*
|
2005-04-26 |
2007-12-20 |
Eisai Co., Ltd. |
Compositions and methods for immunotherapy
|
|
CN101304748A
(zh)
*
|
2005-08-22 |
2008-11-12 |
加利福尼亚大学董事会 |
Tlr激动剂
|
|
JPWO2007034817A1
(ja)
*
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
|
US20090105212A1
(en)
*
|
2005-09-22 |
2009-04-23 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
|
US20070100146A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Trevor Dzwiniel |
Process for the preparation of imidazo[4,5-c]-quinolin-4-amines
|
|
EP2700638A1
(en)
*
|
2006-05-31 |
2014-02-26 |
The Regents Of the University of California |
Purine analogs
|
|
US20080008682A1
(en)
*
|
2006-07-07 |
2008-01-10 |
Chong Lee S |
Modulators of toll-like receptor 7
|
|
US7919490B2
(en)
*
|
2006-10-04 |
2011-04-05 |
Wyeth Llc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
|
US7902187B2
(en)
*
|
2006-10-04 |
2011-03-08 |
Wyeth Llc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
|
CN101790380B
(zh)
*
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
|
CA2691444C
(en)
*
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
WO2009052310A1
(en)
*
|
2007-10-16 |
2009-04-23 |
Cv Therapeutics, Inc |
A3 adenosine receptor antagonists
|
|
KR20110117705A
(ko)
*
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
|
JP5694345B2
(ja)
*
|
2009-10-22 |
2015-04-01 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｔｏｌｌ様受容体の調節因子
|
|
US20120003298A1
(en)
*
|
2010-04-30 |
2012-01-05 |
Alcide Barberis |
Methods for inducing an immune response
|
|
AU2011247358B2
(en)
*
|
2010-04-30 |
2014-10-30 |
Urogen Pharma Ltd. |
Phospholipid drug analogs
|
|
AU2011295853A1
(en)
*
|
2010-09-01 |
2013-04-04 |
Irm Llc |
Adsorption of immunopotentiators to insoluble metal salts
|
|
WO2012038058A1
(en)
*
|
2010-09-21 |
2012-03-29 |
Telormedix Sa |
Treatment of conditions by toll-like receptor modulators
|